Nanomedicine News

RSS

Development of IFPs Important for Future Studies in Animals

Researchers at the University of California, San Diego - led by 2008 Nobel-Prize winner Roger Tsien, PhD - have shown that bacterial proteins called phytochromes can be engineered into infrared-fluorescent proteins (IFPs).

7 May 2009

New Robotic Muscles Can Withstand Extreme Temperatures

Scientists at the University of Texas at Dallas have revealed dramatic advances in artificial muscles that are very fast, highly flexible, incredibly strong, and can withstand temperatures that would melt steel or freeze...

7 May 2009

Applied DNA Sciences Completes Pilot Study for IIMAK

Applied DNA Sciences, Inc. (OTCBB: APDN), a provider of DNA-based security solutions, announced today that it has successfully completed its pilot study of SigNature® DNA in IIMAK thermal transfer ink and ribbons.

7 May 2009

Nanotechnology Researchers Develop Biosensor Capable of Detecting Candida Albicans Yeast

The Nanosensors group from the URV has created a biosensor, an electrical and biological device, which is able to selectively detect the Candida albicans yeast in very small quantities of only 50 cfu/ml (colony-forming units per millilitre).

7 May 2009

CombiMatrix President and CEO to Present at DxRx Summit

CombiMatrix Corporation (Nasdaq:CBMX) today announced Dr. Amit Kumar, President and CEO, will present at the DxRx Summit: Nucleic Acid Diagnostics + Therapeutics in Boston, Massachusetts on May 13th at 11:30 am EDT. The title of Dr. Kumar's presentation is "Non-Invasive, Array-Based Screening for Cancer."

From Invitae Corporation 7 May 2009

ADA Technologies Demonstrates Technical Feasibility of Developing Advanced Lithium-Ion Nano-Batteries

ADA Technologies, Inc. has completed research that demonstrates the technical feasibility of developing advanced lithium-ion nano-batteries. Funded by the National Science Foundation, the $150,000 Phase I research focused on developing high-capacity / high-rate nano-structured electrodes that could be combined with environmentally benign electrolytes to significantly improve lithium-ion battery performance.

From ADA Technologies 6 May 2009

Four-in-One Agent that Can Detect, Target, and Disable Tumor Cells

Diagnosis and treatment in one go: Korean researchers led by Tae Gwan Park and Jinwoo Cheon have developed the basis for a four-in-one agent that can detect, target, and disable tumor cells while also making them macroscopically and microscopically visible. As they report in the journal Angewandte Chemie, their work involves magnetic iron oxide particles with a fluorescence dye, RNA fragments, and a special peptide attached.

6 May 2009